TRPV2 and rheumatoid arthritis: Interestingly, although TRPV2 gene and functional expression is increased in synoviocytes from patients with RA, TRPV2 agonists reduce the in vitro invasiveness of these synoviocytes, as measured by a 24-h invasion assay.